(Total Views: 653)
Posted On: 05/01/2019 11:46:07 AM
Post# of 9144
Re: mitstevfel #4968
Thanks for the additional information.
Every step forward makes NNLX a more appealing buyout for a large diagnostic company. I wonder what it takes for one of them to take a bite? The commercial launch of the first N-Assay product?
If not a buyout, then the demand for the N-Assay should skyrocket as its value in practice is proven. This demand should drive investor money to bring as many N-Assay products to market in as short a time as possible.
Every step forward makes NNLX a more appealing buyout for a large diagnostic company. I wonder what it takes for one of them to take a bite? The commercial launch of the first N-Assay product?
If not a buyout, then the demand for the N-Assay should skyrocket as its value in practice is proven. This demand should drive investor money to bring as many N-Assay products to market in as short a time as possible.
(3)
(1)
